Literature DB >> 19465514

Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment.

Danielle L Burke1, Maria G Frid, Claudia L Kunrath, Vijaya Karoor, Adil Anwar, Brandie D Wagner, Derek Strassheim, Kurt R Stenmark.   

Abstract

Recent studies demonstrate that sustained hypoxia induces the robust accumulation of leukocytes and mesenchymal progenitor cells in pulmonary arteries (PAs). Since the factors orchestrating hypoxia-induced vascular inflammation are not well-defined, the goal of this study was to identify mediators potentially responsible for recruitment to and retention and differentiation of circulating cells within the hypoxic PA. We analyzed mRNA expression of 44 different chemokine/chemokine receptor, cytokine, adhesion, and growth and differentiation genes in PAs obtained via laser capture microdissection in adjacent lung parenchyma and in systemic arteries by RT-PCR at several time points of hypoxic exposure (1, 7, and 28 days) in Wistar-Kyoto rats. Analysis of inflammatory cell accumulation and protein expression of selected genes was concomitantly assessed by immunochemistry. We found that hypoxia induced progressive accumulation of monocytes and dendritic cells in the vessel wall with few T cells and no B cells or neutrophils. Upregulation of stromal cell-derived factor-1 (SDF-1), VEGF, growth-related oncogene protein-alpha (GRO-alpha), C5, ICAM-1, osteopontin (OPN), and transforming growth factor-beta (TGF-beta) preceded mononuclear cell influx. With time, a more complex pattern of gene expression developed with persistent upregulation of adhesion molecules (ICAM-1, VCAM-1, and OPN) and monocyte/fibrocyte growth and differentiation factors (TGF-beta, endothelin-1, and 5-lipoxygenase). On return to normoxia, expression of many genes (including SDF-1, monocyte chemoattractant protein-1, C5, ICAM-1, and TGF-beta) rapidly returned to control levels, changes that preceded the disappearance of monocytes and reversal of vascular remodeling. In conclusion, sustained hypoxia leads to the development of a complex, PA-specific, proinflammatory microenvironment capable of promoting recruitment, retention, and differentiation of circulating monocytic cell populations that contribute to vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465514      PMCID: PMC2742800          DOI: 10.1152/ajplung.90591.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  63 in total

1.  Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries.

Authors:  Joanne L Wright; Hsin Tai; Andrew Churg
Journal:  Am J Respir Cell Mol Biol       Date:  2004-07-08       Impact factor: 6.914

Review 2.  Myeloid cells in atherosclerosis: initiators and decision shapers.

Authors:  Oliver Soehnlein; Christian Weber
Journal:  Semin Immunopathol       Date:  2009-02-24       Impact factor: 9.623

3.  Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts.

Authors:  Rubens Fraga Alves Pinto; Maria de Lourdes Higuchi; Vera Demarchi Aiello
Journal:  Cardiovasc Pathol       Date:  2004 Sep-Oct       Impact factor: 2.185

Review 4.  Pathologic assessment of vasculopathies in pulmonary hypertension.

Authors:  Giuseppe G Pietra; Frederique Capron; Susan Stewart; Ornella Leone; Marc Humbert; Ivan M Robbins; Lynne M Reid; R M Tuder
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

5.  Resolution of pulmonary hypertension and other features induced by chronic hypoxia in rats during complete and intermittent normoxia.

Authors:  J Herget; A J Suggett; E Leach; G R Barer
Journal:  Thorax       Date:  1978-08       Impact factor: 9.139

6.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.

Authors:  Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

7.  Remodelling of the pulmonary arteries during recovery from pulmonary hypertension induced by neonatal hypoxia.

Authors:  Susan M Hall; Alison A Hislop; Zhongshi Wu; Sheila G Haworth
Journal:  J Pathol       Date:  2004-05       Impact factor: 7.996

8.  Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease.

Authors:  Satoshi Fuke; Tomoko Betsuyaku; Yasuyuki Nasuhara; Toshiaki Morikawa; Hiroyuki Katoh; Masaharu Nishimura
Journal:  Am J Respir Cell Mol Biol       Date:  2004-06-25       Impact factor: 6.914

9.  Changes in the pulmonary arteries of the rat during recovery from hypoxia-induced pulmonary hypertension.

Authors:  A Hislop; L Reid
Journal:  Br J Exp Pathol       Date:  1977-12

Review 10.  Inflammation in pulmonary arterial hypertension.

Authors:  P Dorfmüller; F Perros; K Balabanian; M Humbert
Journal:  Eur Respir J       Date:  2003-08       Impact factor: 16.671

View more
  65 in total

1.  Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human Dermis.

Authors:  Alexander M S Barron; Julio C Mantero; Jonathan D Ho; Banafsheh Nazari; Katharine L Horback; Jag Bhawan; Robert Lafyatis; Christina Lam; Jeffrey L Browning
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

Review 2.  HIF and pulmonary vascular responses to hypoxia.

Authors:  Larissa A Shimoda; Steven S Laurie
Journal:  J Appl Physiol (1985)       Date:  2013-12-12

3.  Varicella zoster virus vasculopathy: analysis of virus-infected arteries.

Authors:  M A Nagel; I Traktinskiy; Y Azarkh; B Kleinschmidt-DeMasters; T Hedley-Whyte; A Russman; E M VanEgmond; K Stenmark; M Frid; R Mahalingam; M Wellish; A Choe; R Cordery-Cotter; R J Cohrs; D Gilden
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

Review 4.  Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.

Authors:  Kurt R Stenmark; Rubin M Tuder; Karim C El Kasmi
Journal:  J Appl Physiol (1985)       Date:  2015-04-30

Review 5.  Inflammation in Pulmonary Arterial Hypertension.

Authors:  Timothy Klouda; Ke Yuan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Bone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension.

Authors:  Ling Yan; Xinping Chen; Megha Talati; Bethany Womack Nunley; Santhi Gladson; Tom Blackwell; Joy Cogan; Eric Austin; Ferrin Wheeler; James Loyd; James West; Rizwan Hamid
Journal:  Am J Respir Crit Care Med       Date:  2016-04-15       Impact factor: 21.405

Review 7.  [Chronic hypoxia and cardiovascular risk : Clinical significance of different forms of hypoxia].

Authors:  U Koehler; O Hildebrandt; J Krönig; W Grimm; J Otto; W Hildebrandt; R Kinscherf
Journal:  Herz       Date:  2017-05-04       Impact factor: 1.443

8.  VCAM-1 is a TGF-β1 inducible gene upregulated in idiopathic pulmonary fibrosis.

Authors:  Marianna Agassandian; John R Tedrow; John Sembrat; Daniel J Kass; Yingze Zhang; Elena A Goncharova; Naftali Kaminski; Rama K Mallampalli; Louis J Vuga
Journal:  Cell Signal       Date:  2015-09-18       Impact factor: 4.315

9.  Implication of in vivo circulating fibrocytes ablation in experimental pulmonary hypertension murine model.

Authors:  Vandana S Nikam; Sandeep Nikam; Akyl Sydykov; Katrin Ahlbrecht; Rory E Morty; Werner Seeger; Robert Voswinckel
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

10.  Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome.

Authors:  Leah R Villegas; Dylan Kluck; Carlie Field; Rebecca E Oberley-Deegan; Crystal Woods; Michael E Yeager; Karim C El Kasmi; Rashmin C Savani; Russell P Bowler; Eva Nozik-Grayck
Journal:  Antioxid Redox Signal       Date:  2013-02-05       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.